-
Platycodin D Targets RFC4–Notch Signaling in NSCLC
2026-10-07
A 2026 Molecular & Cellular Proteomics pre-proof integrates thermal proteome profiling, stability assays, molecular docking, proteomics, and ubiquitinomics to identify RFC4 as a candidate target of Platycodin D in non-small cell lung cancer. The study links RFC4-associated changes to reduced Notch1/Notch3 signaling and apoptosis, while its pre-proof status and cell-based evidence define important limits on translation.
-
SmD2 Acetylation, Splicing, and PARP Sensitivity in HCC
2026-10-07
A 2024 Nature Communications study identifies SmD2 acetylation as a regulatory link between spliceosome function, BRCA1/FANC cassette-exon usage, DNA-damage responses, and PARP-inhibitor sensitivity in hepatocellular carcinoma. Its findings provide a mechanistic rationale for combining HDAC-directed treatment with PARP inhibition, while remaining primarily preclinical and model dependent.
-
MTM2 Links ER Exit Sites to Autophagy Control
2026-10-07
A 2025 Arabidopsis study identifies Myotubularin 2 (MTM2) as a phosphatidylinositol 3-phosphate phosphatase at ER exit sites that restrains autophagy. The work connects PtdIns3P turnover, SEC23A-dependent COPII function, autophagic flux, and salt-stress adaptation while defining important boundaries for interpreting Concanamycin A-related experiments.
-
Romidepsin and Proteomic Mechanism Mapping
2026-10-06
Romidepsin and FK228 are powerful tools for studying class I HDAC biology, but phenotype alone cannot establish mechanism. This article connects their epigenetic effects with a multidimensional proteomics framework while defining evidence limits and research opportunities.
-
Chloroquine BA1002: Product Identity and Scope
2026-10-05
Chloroquine (BA1002) is a supplier-listed 4-aminoquinoline compound with conceptual relevance to malaria, rheumatoid arthritis, autophagy, and Toll-like receptor research. No matched paper evidence is available for this product entry.
-
BQCA and the Next Era of M1 Translation
2026-10-05
Benzyl Quinolone Carboxylic Acid (BQCA) offers a useful lens for understanding M1 receptor potentiation, GRK-dependent signaling bias, and the evidence requirements for translational neuroscience.
-
AMPK, ULK1, and Autophagy Under Energy Stress
2026-10-04
Park, Lee, and Kim challenge the prevailing view that AMPK broadly activates autophagy during glucose deprivation. Their evidence indicates that AMPK restrains ULK1–ATG14–Vps34 signaling during severe energy stress while preserving autophagy machinery for recovery after stress subsides.
-
Ouabain: Na⁺/K⁺-ATPase Inhibition in Research
2026-10-03
Ouabain is a classic cardiac glycoside and selective Na⁺/K⁺-ATPase inhibitor used to study ion transport, calcium handling, membrane signaling, and cardiovascular physiology. This overview separates established mechanistic context from supplier-reported applications and examines how ouabain relates to emerging senolytic research, including the evidence limits that constrain translation from cell models to animal or clinical settings.
-
Epigenetic and Genetic Programming of T Cells
2026-10-02
The reference study develops an all-RNA CRISPRoff and CRISPRon platform for durable, multiplexed control of endogenous gene expression in primary human T cells without requiring sustained editor expression. It also combines epigenetic programming with targeted CAR knock-in, providing a preclinical framework for engineering T-cell products while reducing reliance on multiplexed Cas9-mediated double-strand-break editing.
-
Romidepsin (FK228) for HDAC2–SmD2 Assays
2026-10-01
Romidepsin (FK228) is a high-potency class I HDAC probe for connecting chromatin acetylation with spliceosome behavior, DNA-repair phenotypes, and PARP-inhibitor response. This practical guide translates the HDAC2–SmD2 findings in hepatocellular carcinoma into dose planning, mechanistic readouts, combination testing, and troubleshooting workflows.
-
Diethylmaleate Workflows for Redox Research
2026-10-01
Diethylmaleate enables controlled glutathione depletion for testing GST activity, ROS signaling, apoptosis, and chemical sensitivity. This workflow-focused guide connects insecticide-resistance evidence with practical cell, biochemical, and comparative toxicology applications while emphasizing controls, storage, and troubleshooting.
-
LIRP Enables Light-Controlled Gene Therapy
2026-09-30
The reference study presents a rationally designed light-inducible RNA-releasing protein (LIRP) that suppresses therapeutic mRNA translation in darkness and permits expression under blue or ambient light. In mouse models, LIRP-regulated AAV2 systems controlled metabolic and retinal interventions, illustrating how translational gene switches may improve temporal precision and safety in gene therapy.
-
L-Ornithine and the Liver–Brain Metabolic Axis
2026-09-30
L-Ornithine is more than a urea cycle intermediate: it is a practical probe for connecting hepatic ammonia detoxification with astrocyte energy metabolism. This article translates recent liver–brain axis findings into compartment-aware assay strategies for amino acid metabolism research.
-
Regorafenib: From Kinase Map to Melanoma Mechanism
2026-09-29
Regorafenib (BAY 73-4506) is more than a broad-spectrum kinase probe: emerging melanoma evidence connects its activity to RRM2 reduction and ERK/E2F3 signaling. This article translates that mechanistic insight into experimental design, biomarker strategy, and translational decision-making.
-
HyperScript RT SuperMix for qPCR: Variant-to-Assay
2026-09-29
HyperScript RT SuperMix for qPCR supports reliable cDNA synthesis for qPCR when RNA structure or limited template complicates gene expression analysis. This article develops a variant-informed framework linking the FBN1 case report to practical reverse-transcription and assay-design decisions.